We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Brain Stem Cells Produce Insulin

By Biotechdaily staff writers
Posted on 13 May 2005
Researchers have been able to coax stem cells from the brain to mature into cells that can produce insulin and release it when sugar is added to the environment. More...
This feat could lead to new ways of transplanting insulin-producing cells into diabetics.

Because embryonic stem cells are difficult to work with in a laboratory and most existing human embryonic stem cells lines are contaminated and cannot be transplanted into humans, an alternative was sought by Seung Kim, M.D., Ph.D., assisstant professor of developmental biology at the Stanford University School of Medicine (Palo Alto, CA).

Dr. Kim thought that human neural stem cells might work. "When you look at islet cells you realize that they resemble neurons,” he noted. Like neurons, islet cells respond to external signals by changing their electrical properties and releasing packages of proteins. In the case of islets, that protein is insulin. In fact, the cells that produce insulin and regulate sugar in fruit flies are neurons.

Working with the cells in a lab dish, Dr. Kim and postdoctoral fellow Yuichi Hori, M.D., Ph.D., added a cocktail of chemicals in a sequence they knew might prod the stem cells to mature into insulin-producing cells. The result was a dish full of cells that could produce insulin and release it in response to sugar being added. These cells did not perfectly mimic human islet cells. They made some, but not all, proteins normally made by islet cells and they continued to make some proteins found in neurons.

Dr. Kim then transplanted the cells into a cavity in the kidneys of mice. When the blood sugar went up in these mice, the cells released insulin. After four weeks, the cells were still alive and producing insulin. Although the amount of insulin produced was not enough to treat diabetes, the work is a first step toward that eventual goal. Dr. Kim is the lead author of a paper describing the project, published in the April 26, 2005, issue of PLoS Medicine.


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LIAISON Murex Anti-HDV Immunoassay is the first fully automated FDA-authorized immunoassay for HDV detection in the U.S. (Photo courtesy of Diasorin)

Fully Automated Immunoassay Test Detects HDV Co‑Infection and Super-Infection

Hepatitis delta, also known as hepatitis D, is caused by the hepatitis delta virus (HDV). It is a viral liver infection that can result in one of the most severe forms of viral hepatitis.... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.